Patents by Inventor George C. Stewart
George C. Stewart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12103222Abstract: A drawn fused filament fabrication method of three-dimensional printing is disclosed in which the filament extruded is variable and not restricted to the diameter of the nozzle used for extrusion. This method composes three steps. The first is to extrude a small amount of material at a starting position. Next, the extruding head pulls the extruded material along while moving away from the starting position. During this time to material cools down and solidifies. As a result, a thin filament is formed. Third, once the extruding head moves to a destination, a small amount of material can be extruded and deposited to anchor this newly formed filament to a surface. The drawn fused filament fabrication method may be used to print three-dimensional parts having significant lower thickness than the diameter of the nozzle used to extrude the printing material.Type: GrantFiled: December 23, 2019Date of Patent: October 1, 2024Assignees: THE CURATORS OF THE UNIVERSITY OF MISSOURI, TIGER ENERGY SOLUTIONS, LLCInventors: Ronald Wood, Hsin-Yeh Hsieh, Chung-Ho Lin, George C. Stewart, Mason W. Schellenberg, Shibu Jose
-
Patent number: 11401498Abstract: Herein a Bacillus exosporium antigen delivery (BEAD) system that provides a means to introduce recombinant proteins or small molecules into the exosporium of members of the B. cereus family of bacteria, i.e. B. anthracis, B. cereus, and B. thuringiensis, is disclosed. The system results in the surface display of recombinant proteins or small molecules such that they can stimulate an immune response. In addition, methods of making and using the system are described.Type: GrantFiled: April 27, 2018Date of Patent: August 2, 2022Assignee: The Curators of the University of MissouriInventors: George C. Stewart, Brian Matthew Thompson
-
Publication number: 20220072764Abstract: A drawn fused filament fabrication method of three-dimensional printing is disclosed in which the filament extruded is variable and not restricted to the diameter of the nozzle used for extrusion. This method composes three steps. The first is to extrude a small amount of material at a starting position. Next, the extruding head pulls the extruded material along while moving away from the starting position. During this time to material cools down and solidifies. As a result, a thin filament is formed. Third, once the extruding head moves to a destination, a small amount of material can be extruded and deposited to anchor this newly formed filament to a surface. The drawn fused filament fabrication method may be used to print three-dimensional parts having significant lower thickness than the diameter of the nozzle used to extrude the printing material.Type: ApplicationFiled: December 23, 2019Publication date: March 10, 2022Inventors: Ronald Wood, Hsin-Yeh Hsieh, Chung-Ho Lin, George C. Stewart, Mason W. Schellenberg, Shibu Jose
-
Patent number: 10081790Abstract: Herein a Bacillus exosporium molecule delivery (BEMD) system that provides a means to deliver molecules of interest (MOIs) to an environment is disclosed. The system results in the display of MOIs on the exosporium surface of Bacillus family members such that they can be delivered to an environment in a stable and active form. In addition, methods of making and using the system are described.Type: GrantFiled: September 9, 2015Date of Patent: September 25, 2018Assignee: The Curators of the University of MissouriInventors: George C. Stewart, Brian Matthew Thompson, Chung-Ho Lin
-
Publication number: 20180250377Abstract: Herein a Bacillus exosporium antigen delivery (BEAD) system that provides a means to introduce recombinant proteins or small molecules into the exosporium of members of the B. cereus family of bacteria, i.e. B. anthracis, B. cereus, and B. thuringiensis, is disclosed. The system results in the surface display of recombinant proteins or small molecules such that they can stimulate an immune response. In addition, methods of making and using the system are described.Type: ApplicationFiled: April 27, 2018Publication date: September 6, 2018Inventors: George C. Stewart, Brian Matthew Thompson
-
Patent number: 9956277Abstract: Herein a Bacillus exosporium antigen delivery (BEAD) system that provides a means to introduce recombinant proteins or small molecules into the exosporium of members of the B. cereus family of bacteria, i.e. B. anthracis, B. cereus, and B. thuringiensis, is disclosed. The system results in the surface display of recombinant proteins or small molecules such that they can stimulate an immune response. In addition, methods of making and using the system are described.Type: GrantFiled: September 9, 2015Date of Patent: May 1, 2018Assignee: The Curators of the University of MissouriInventors: George C. Stewart, Brian Matthew Thompson
-
Publication number: 20160053222Abstract: Herein a Bacillus exosporium molecule delivery (BEMD) system that provides a means to deliver molecules of interest (MOIs) to an environment is disclosed. The system results in the display of MOIs on the exosporium surface of Bacillus family members such that they can be delivered to an environment in a stable and active form. In addition, methods of making and using the system are described.Type: ApplicationFiled: September 9, 2015Publication date: February 25, 2016Inventors: George C. Stewart, Brian Matthew Thompson, Chung-Ho Lin
-
Publication number: 20160051656Abstract: Herein a Bacillus exosporium antigen delivery (BEAD) system that provides a means to introduce recombinant proteins or small molecules into the exosporium of members of the B. cereus family of bacteria, i.e. B. anthracis, B. cereus, and B. thuringiensis, is disclosed. The system results in the surface display of recombinant proteins or small molecules such that they can stimulate an immune response. In addition, methods of making and using the system are described.Type: ApplicationFiled: September 9, 2015Publication date: February 25, 2016Inventors: George C. Stewart, Brian Matthew Thompson
-
Patent number: 9132175Abstract: Herein a Bacillus exosporium molecule delivery (BEMD) system that provides a means to deliver molecules of interest (MOIs) to an environment is disclosed. The system results in the display of MOIs on the exosporium surface of Bacillus family members such that they can be delivered to an environment in a stable and active form. In addition, methods of making and using the system are described.Type: GrantFiled: April 18, 2011Date of Patent: September 15, 2015Assignee: The Curators of the University of MissouriInventors: George C. Stewart, Brian Matthew Thompson
-
Patent number: 9133251Abstract: Herein a Bacillus exosporium antigen delivery (BEAD) system that provides a means to introduce recombinant proteins or small molecules into the exosporium of members of the B. cereus family of bacteria, i.e. B. anthracis, B. cereus, and B. thuringiensis, is disclosed. The system results in the surface display of recombinant proteins or small molecules such that they can stimulate an immune response. In addition, methods of making and using the system are described.Type: GrantFiled: February 23, 2009Date of Patent: September 15, 2015Assignee: The Curators of the University of MissouriInventors: George C. Stewart, Brian Matthew Thompson
-
Publication number: 20110281316Abstract: Herein a Bacillus exosporium molecule delivery (BEMD) system that provides a means to deliver molecules of interest (MOIs) to an environment is disclosed. The system results in the display of MOIs on the exosporium surface of Bacillus family members such that they can be delivered to an environment in a stable and active form. In addition, methods of making and using the system are described.Type: ApplicationFiled: April 18, 2011Publication date: November 17, 2011Applicant: The Curators of the University of MissouriInventors: George C. Stewart, Brian Matthew Thompson
-
Publication number: 20100233124Abstract: Herein a Bacillus exosporium antigen delivery (BEAD) system that provides a means to introduce recombinant proteins or small molecules into the exosporium of members of the B. cereus family of bacteria, i.e. B. anthracis, B. cereus, and B. thuringiensis, is disclosed. The system results in the surface display of recombinant proteins or small molecules such that they can stimulate an immune response. In addition, methods of making and using the system are described.Type: ApplicationFiled: February 23, 2009Publication date: September 16, 2010Applicant: The Curators of the University of MissouriInventors: George C. Stewart, Brian Matthew Thompson
-
Publication number: 20090117142Abstract: The F. necrophorum gene expressing leukotoxin was sequenced and cloned. The leukotoxin open reading frame (lktA) is part of a multi-gene operon containing 9,726 bp, and encoding a protein containing 3,241 amino acids with an overall molecular weight of 335,956 daltons. The protein encoded by the gene was truncated into five polypeptides having overlapping regions by truncating the full length gene into five different sections and amplifying, expressing, and recovering the protein encoded by each of these sections. Additionally, a region upstream of the gene was sequenced and the polypeptide encoded by that nucleotide sequence was purified and isolated. These polypeptides along with the full length protein are then tested to determine their immunogenicity and protective immunity in comparison to the efficacy of immunization conferred by inactivated native leukotoxin in F. necrophorum culture supernatant.Type: ApplicationFiled: July 11, 2008Publication date: May 7, 2009Applicant: KANSAS STATE UNIVERSITY RESEARCH FOUNDATIONInventors: Tiruvoor G. Nagaraja, George C. Stewart, Sanjeev K. Narayanan, Muckatira M. Chengappa
-
Patent number: 7449310Abstract: The F. necrophorum gene expressing leukotoxin was sequenced and cloned. The leukotoxin open reading frame (lktA) is part of a multi-gene operon containing 9,726 bp, and encoding a protein containing 3,241 amino acids with an overall molecular weight of 335,956 daltons. The protein encoded by the gene was truncated into five polypeptides having overlapping regions by truncating the full length gene into five different sections and amplifying, expressing, and recovering the protein encoded by each of these sections. Additionally, a region upstream of the gene was sequenced and the polypeptide encoded by that nucleotide sequence was purified and isolated. These polypeptides along with the full length protein are then tested to determine their immunogenicity and protective immunity in comparison to the efficacy of immunization conferred by inactivated native leukotoxin in F. necrophorum culture supernatant.Type: GrantFiled: August 22, 2003Date of Patent: November 11, 2008Assignee: Kansas State University Research FoundationInventors: Tiruvoor G. Nagaraja, George C. Stewart, Sanjeev K. Narayanan, Muckatira M. Chengappa
-
Publication number: 20040047871Abstract: The F. necrophorum gene expressing leukotoxin was sequenced and cloned. The leukotoxin open reading frame (lktA) is part of a multi-gene operon containing 9,726 bp, and encoding a protein containing 3,241 amino acids with an overall molecular weight of 335,956 daltons. The protein encoded by the gene was truncated into five polypeptides having overlapping regions by truncating the full length gene into five different sections and amplifying, expressing, and recovering the protein encoded by each of these sections. Additionally, a region upstream of the gene was sequenced and the polypeptide encoded by that nucleotide sequence was purified and isolated. These polypeptides along with the full length protein are then tested to determine their immunogenicity and protective immunity in comparison to the efficacy of immunization conferred by inactivated native leukotoxin in F. necrophorum culture supernatant.Type: ApplicationFiled: August 22, 2003Publication date: March 11, 2004Inventors: T.G. Nagaraja, George C. Stewart, Sanjeev K. Narayanan, M.M. Chengappa
-
Patent number: 6669940Abstract: The F. necrophorum gene expressing leukotoxin was sequenced and cloned. The leukotoxin open reading frame (lktA) is part of a multi-gene operon containing 9,726 bp, and encoding a protein containing 3,241 amino acids with an overall molecular weight of 335,956 daltons. The protein encoded by the gene was truncated into five polypeptides having overlapping regions by truncating the full length gene into five different sections and amplifying, expressing, and recovering the protein encoded by each of these sections. Additionally, a region upstream of the gene was sequenced and the polypeptide encoded by that nucleotide sequence was purified and isolated. These polypeptides along with the full length protein are then tested to determine their immunogenicity and protective immunity in comparison to the efficacy of immunization conferred by inactivated native leukotoxin in F. necrophorum culture supernatant.Type: GrantFiled: April 24, 2001Date of Patent: December 30, 2003Assignee: Kansas University Research FoundationInventors: Tiruvoor G. Nagaraja, George C. Stewart, Sanjeev K. Narayanan, Muckatira M. Chengappa
-
Publication number: 20020054883Abstract: The F. necrophorum gene expressing leukotoxin was sequenced and cloned. The leukotoxin open reading frame (lktA) is part of a multi-gene operon containing 9,726 bp, and encoding a protein containing 3,241 amino acids with an overall molecular weight of 335,956 daltons. The protein encoded by the gene was truncated into five polypeptides having overlapping regions by truncating the full length gene into five different sections and amplifying, expressing, and recovering the protein encoded by each of these sections. Additionally, a region upstream of the gene was sequenced and the polypeptide encoded by that nucleotide sequence was purified and isolated. These polypeptides along with the full length protein are then tested to determine their immunogenicity and protective immunity in comparison to the efficacy of immunization conferred by inactivated native leukotoxin in F. necrophorum culture supernatant.Type: ApplicationFiled: April 24, 2001Publication date: May 9, 2002Inventors: T.G. Nagaraja, George C. Stewart, Sanjeev K. Narayanan, M. M. Chengappa